deucravacitinib
bms
['deucra', 'iber ,(-viber)', 'lattice-uc', ' uc ', 'ibd', 'iber ']
#stefanschreiber efficacy of deucravacitinib, an oral, selective, tyrosine kinase 2 inhibitor, in bio-experienced uc pts. (p-ii lattice-uc study)#uegw2022 #ibd - colonic transcriptomics: inf-g responsive genes decreased
- higher dose in piii needed 
Professor of Medicine, Gastroenterologist, specializing in the care of patients with IBD.
National representative of Germany @ https://t.co/Qr0PthTmU8 ex @Y_ECCO_IBD chair